Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-05 5:11 pm Purchase | 2024-03-26 | 13G | iBio, Inc. IBIO | ADAR1 Partners LP | 789,293 9.270% | 789,293 (New Position) | Filing History |
| 2024-03-14 07:42 am Purchase | 2024-03-04 | 13G | Homology Medicines, Inc. FIXX | ADAR1 Partners LP | 173,379 5.400% | 173,379 (New Position) | Filing History |
| 2024-02-23 4:00 pm Purchase | 2024-02-15 | 13G | AVROBIO, Inc. AVRO | ADAR1 Partners LP | 273,042 7.400% | 273,042 (New Position) | Filing History |
| 2024-02-22 4:46 pm Purchase | 2024-02-13 | 13G | Merrimack Pharmaceuticals, Inc. MACK | ADAR1 Partners LP | 902,350 6.300% | 902,350 (New Position) | Filing History |
| 2024-01-31 08:00 am Purchase | 2024-01-23 | 13G | Cellectar Biosciences, Inc. CLRB | ADAR1 Partners LP | 1,824,063 6.210% | 1,824,063 (New Position) | Filing History |
| 2023-07-20 08:00 am Purchase | 2023-07-10 | 13G | Surface Oncology, Inc. SURF | ADAR1 Partners LP | 3,183,242 5.240% | 3,183,242 (New Position) | Filing History |
| 2022-09-30 2:41 pm Purchase | 2022-09-22 | 13G | Social Capital Hedosophia Holdings Corp. VI IPOF | ADAR1 Partners LP | 7,688,476 6.690% | 7,688,476 (New Position) | Filing History |
| 2022-07-27 4:25 pm Purchase | 2022-07-18 | 13G | FAST Acquisition Corp. FST | ADAR1 Partners LP | 1,341,700 6.709% | 1,341,700 (New Position) | Filing History |